These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9123113)

  • 1. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.
    Mazzaferro V; Regalia E; Pulvirenti A; Tagger A; Andreola S; Pasquali M; Baratti D; Romano F; Palazzo U; Zuin M; Bonino F; Ribero ML; Gennari L
    Transplant Proc; 1997; 29(1-2):519-21. PubMed ID: 9123113
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.
    Götz G; Schön MR; Haefker A; Neuhaus R; Berg T; Hopf U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2104-6. PubMed ID: 9723407
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C.
    Bizollon T; Adham M; Pradat P; Chevallier M; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Transplantation; 2005 Feb; 79(3):325-9. PubMed ID: 15699763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation.
    Castedal M; Siewert-Delle A; Olausson M; Friman S
    Transplant Proc; 2003 Mar; 35(2):820-1. PubMed ID: 12644153
    [No Abstract]   [Full Text] [Related]  

  • 5. Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation.
    Mukherjee S; Rogge J; Weaver L; Schafer DF
    Transplant Proc; 2003 Dec; 35(8):3042-4. PubMed ID: 14697974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.
    Werner CR; Egetemeyr DP; Lauer UM; Nadalin S; Königsrainer A; Malek NP; Berg CP
    Liver Transpl; 2012 Dec; 18(12):1464-70. PubMed ID: 22941516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation.
    Wietzke P; Braun F; Ringe B; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2539-42. PubMed ID: 11120284
    [No Abstract]   [Full Text] [Related]  

  • 8. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
    Bizollon T; Ducerf C; Trépo C
    J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2000 Jun; 32(4):714-6. PubMed ID: 10856556
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
    Crippin JS; McCashland T; Terrault N; Sheiner P; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):350-5. PubMed ID: 11965579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study.
    Lee SS; Kilvert L; Liu H; Trepanier J
    Dig Liver Dis; 2016 Mar; 48(3):344. PubMed ID: 26459137
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.
    Tan AC; Brouwer JT; Glue P; van Leusen R; Kauffmann RH; Schalm SW; de Vries RA; Vroom B
    Nephrol Dial Transplant; 2001 Jan; 16(1):193-5. PubMed ID: 11209032
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
    Nair S; Lipscomb J; Eason J
    Transplantation; 2008 Aug; 86(3):418-22. PubMed ID: 18698245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.
    Ueda Y; Takada Y; Marusawa H; Egawa H; Uemoto S; Chiba T
    Transplantation; 2010 Sep; 90(6):661-5. PubMed ID: 20110853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology.
    Kornberg A; Hommann M; Tannapfel A; Grube T; Schotte U; Scheele J
    Transplant Proc; 2002 Sep; 34(6):2259-60. PubMed ID: 12270389
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients.
    Kornberg A; Hommann M; Tannapfel A; Wagner T; Grube T; Schotte U; Voigt R; Scheele J
    Am J Transplant; 2001 Nov; 1(4):350-5. PubMed ID: 12099379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy.
    Babatin M; Schindel L; Burak KW
    Can J Gastroenterol; 2005 Jun; 19(6):359-65. PubMed ID: 15997269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.